161 related articles for article (PubMed ID: 22308859)
1. Use of nocturnal melatonin concentration and urinary 6-sulfatoxymelatonin excretion to evaluate melatonin status in children with severe sepsis.
Bagci S; Yildizdas D; Horoz OO; Reinsberg J; Bartmann P; Mueller A
J Pediatr Endocrinol Metab; 2011; 24(11-12):1025-30. PubMed ID: 22308859
[TBL] [Abstract][Full Text] [Related]
2. Melatonin status in pediatric intensive care patients with sepsis.
Bagci S; Horoz ÖÖ; Yildizdas D; Reinsberg J; Bartmann P; Müller A
Pediatr Crit Care Med; 2012 Mar; 13(2):e120-3. PubMed ID: 21478801
[TBL] [Abstract][Full Text] [Related]
3. Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis.
Mundigler G; Delle-Karth G; Koreny M; Zehetgruber M; Steindl-Munda P; Marktl W; Ferti L; Siostrzonek P
Crit Care Med; 2002 Mar; 30(3):536-40. PubMed ID: 11990911
[TBL] [Abstract][Full Text] [Related]
4. Daily Changes in the Expression of Clock Genes in Sepsis and Their Relation with Sepsis Outcome and Urinary Excretion of 6-Sulfatoximelatonin.
Acuña-Fernández C; Marín JS; Díaz-Casado ME; Rusanova I; Darias-Delbey B; Pérez-Guillama L; Florido-Ruiz J; Acuña-Castroviejo D
Shock; 2020 May; 53(5):550-559. PubMed ID: 31403491
[TBL] [Abstract][Full Text] [Related]
5. Urinary melatonin: a noninvasive method to follow human pineal function as studied in three experimental conditions.
Pääkkönen T; Mäkinen TM; Leppäluoto J; Vakkuri O; Rintamäki H; Palinkas LA; Hassi J
J Pineal Res; 2006 Mar; 40(2):110-5. PubMed ID: 16441547
[TBL] [Abstract][Full Text] [Related]
6. Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients.
Riutta A; Ylitalo P; Kaukinen S
Intensive Care Med; 2009 Oct; 35(10):1720-7. PubMed ID: 19578832
[TBL] [Abstract][Full Text] [Related]
7. Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: lessons from cirrhosis.
Montagnese S; Middleton B; Corrias M; Mani AR; Skene DJ; Morgan MY
Chronobiol Int; 2015 Mar; 32(2):187-94. PubMed ID: 25264562
[TBL] [Abstract][Full Text] [Related]
8. Sulphatoxy melatonin: an index of depression in anorexia nervosa and bulimia nervosa.
Kennedy SH; Brown GM; Garfinkel PE; McVey G; Parienti V
Psychiatry Res; 1990 Jun; 32(3):221-7. PubMed ID: 2388965
[TBL] [Abstract][Full Text] [Related]
9. Prediction of nocturnal plasma melatonin from morning urinary measures.
Graham C; Cook MR; Kavet R; Sastre A; Smith DK
J Pineal Res; 1998 May; 24(4):230-8. PubMed ID: 9572533
[TBL] [Abstract][Full Text] [Related]
10. Postoperative elevated cortisol excretion is not associated with suppression of 6-sulfatoxymelatonin excretion.
Derenzo J; Macknight B; DiVittore NA; Bonafide CP; Cronin AJ
Acta Anaesthesiol Scand; 2005 Jan; 49(1):52-7. PubMed ID: 15675982
[TBL] [Abstract][Full Text] [Related]
11. Long-term alteration of daily melatonin, 6-sulfatoxymelatonin, cortisol, and temperature profiles in burn patients: a preliminary report.
Pina G; Brun J; Tissot S; Claustrat B
Chronobiol Int; 2010 Jan; 27(2):378-92. PubMed ID: 20370476
[TBL] [Abstract][Full Text] [Related]
12. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression.
Crasson M; Kjiri S; Colin A; Kjiri K; L'Hermite-Baleriaux M; Ansseau M; Legros JJ
Psychoneuroendocrinology; 2004 Jan; 29(1):1-12. PubMed ID: 14575725
[TBL] [Abstract][Full Text] [Related]
13. Daytime 50 Hz magnetic field exposure and plasma melatonin and urinary 6-sulfatoxymelatonin concentration profiles in humans.
Crasson M; Beckers V; Pequeux C; Claustrat B; Legros JJ
J Pineal Res; 2001 Oct; 31(3):234-41. PubMed ID: 11589758
[TBL] [Abstract][Full Text] [Related]
14. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal urine melatonin and 6-sulphatoxymelatonin excretion at the acute stage of ischaemic stroke.
Ritzenthaler T; Nighoghossian N; Berthiller J; Schott AM; Cho TH; Derex L; Brun J; Trouillas P; Claustrat B
J Pineal Res; 2009 Apr; 46(3):349-52. PubMed ID: 19317798
[TBL] [Abstract][Full Text] [Related]
16. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations.
Bartsch C; Bartsch H; Schmidt A; Ilg S; Bichler KH; Flüchter SH
Clin Chim Acta; 1992 Aug; 209(3):153-67. PubMed ID: 1395046
[TBL] [Abstract][Full Text] [Related]
17. Mice convert melatonin to 6-sulphatoxymelatonin.
Skene DJ; Timbers SE; Middleton B; English J; Kopp C; Tobler I; Ioannides C
Gen Comp Endocrinol; 2006 Jul; 147(3):371-6. PubMed ID: 16564048
[TBL] [Abstract][Full Text] [Related]
18. Disrupted nocturnal melatonin in autism: Association with tumor necrosis factor and sleep disturbances.
da Silveira Cruz-Machado S; Guissoni Campos LM; Fadini CC; Anderson G; Markus RP; Pinato L
J Pineal Res; 2021 Apr; 70(3):e12715. PubMed ID: 33421193
[TBL] [Abstract][Full Text] [Related]
19. Secretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia.
Chojnacki C; Poplawski T; Klupinska G; Blasiak J; Chojnacki J; Reiter RJ
World J Gastroenterol; 2011 Jun; 17(21):2646-51. PubMed ID: 21677834
[TBL] [Abstract][Full Text] [Related]
20. Annual changes in 6-sulphatoxymelatonin excretion in man.
Bojkowski CJ; Arendt J
Acta Endocrinol (Copenh); 1988 Apr; 117(4):470-6. PubMed ID: 3389039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
